Table 2.
Subgroup analysis.
| Baseline HbA1c (%) | Follow-Up HbA1c (%) | Change in HbA1c (%) | p-Value | p-Value between Groups | |
|---|---|---|---|---|---|
| n = 42 | |||||
| <55 years (n = 12) | 8.42 ± 0.95 | 7.09 ± 1.12 | −1.32 ± 1.25 | 0.004 | 0.20 |
| >55 years (n = 30) | 7.66 ± 0.97 | 6.88 ± 0.78 | −0.78 ± 0.98 | <0.001 | |
| n = 42 | |||||
| Baseline HbA1c < 8% (n = 24) | 7.17 ± 0.44 | 6.74 ± 0.76 | −0.43 ± 0.75 | 0.01 | <0.001 |
| Baseline HbA1c > 8% (n = 18) | 8.81 ± 0.77 | 7.21 ± 0.97 | −1.61 ± 1.1 | <0.001 | |
| n = 42 | |||||
| Baseline BMI < 30 (n = 12) | 7.68 ± 1.05 | 7.07 ± 0.77 | −0.6 ± 0.98 | 0.06 | 0.16 |
| Baseline BMI > 30 (n = 30) | 7.99 ± 1 | 6.89 ± 0.94 | −1.10 ± 1.11 | <0.001 | |
| n = 26 * | |||||
| Duration < 8.5 years (n = 15) | 7.6 ± 1.14 | 6.76 ± 0.88 | −0.84 ± 1.31 | 0.008 | 0.58 |
| Duration > 8.5 years (n = 11) | 8.21 ± 0.64 | 7.1 ± 1.04 | −1.12 ± 1.19 | 0.03 | |
| n = 42 | |||||
| Male (n = 23) | 7.88 ± 0.98 | 6.86 ± 0.88 | −1.02 ± 1.1 | <0.001 | 0.57 |
| Female (n = 19) | 7.86 ± 1.08 | 7.04 ± 0.91 | −0.83 ± 1.07 | 0.003 |
* Diabetes duration was provided voluntarily, which resulted in the data of only 26 participants (61.9%) being analyzed.